Who owns Marker Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MRKR from SEC Form 13F filings across 35 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 35 institutions disclosed 4.0M shares of Marker Therapeutics, Inc. worth $5.8M — about 20.6% of shares outstanding; the largest disclosed holder is NEA Management Company, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
35
13F holders
$5.8M
value, 2026 filers
20.6%
of shares outstanding (4.0M sh)
5
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of MRKR's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | NEA Management Company, LLC | 1.6M | $2.4M | 0.2% | 8.4% | 0.0% |
| 2 | Blue Owl Capital Holdings LP | 554,250 | $814,748 | 0.1% | 2.9% | 0.0% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 426,169 | $626,468 | 0.0% | 2.2% | +9.5% |
| 4 | Aisling Capital Management LP | 325,370 | $478,293 | 0.1% | 1.7% | 0.0% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | 249,423 | $366,652 | 0.0% | 1.3% | +42.3% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 139,816 | $205,558 | 0.0% | 0.7% | -13.1% |
| 7 | OSAIC HOLDINGS, INC. | 112,649 | $165,590 | 0.0% | 0.6% | +21.0% |
| 8 | VANGUARD FIDUCIARY TRUST CO | 87,269 | $128,285 | 0.0% | 0.5% | 0.0% |
| 9 | LPL Financial LLC | 83,147 | $122,226 | 0.0% | 0.4% | +0.1% |
| 10 | Concurrent Investment Advisors, LLCNEW | 67,963 | $99,906 | 0.0% | 0.4% | new |
| 11 | TWO SIGMA INVESTMENTS, LP | 60,201 | $88,495 | 0.0% | 0.3% | -1.3% |
| 12 | XTX Topco Ltd | 45,357 | $66,675 | 0.0% | 0.2% | -28.6% |
| 13 | NORTHERN TRUST CORP | 34,629 | $50,905 | 0.0% | 0.2% | +33.1% |
| 14 | CITADEL ADVISORS LLCNEW | 32,517 | $47,800 | 0.0% | 0.2% | new |
| 15 | STATE STREET CORP | 20,948 | $30,794 | 0.0% | 0.1% | 0.0% |
| 16 | Invst, LLC | 18,000 | $26,460 | 0.0% | 0.1% | -37.9% |
| 17 | Creative Planning | 17,312 | $25,449 | 0.0% | 0.1% | 0.0% |
| 18 | JANE STREET GROUP, LLC | 16,832 | $24,743 | 0.0% | 0.1% | -53.6% |
| 19 | Ashton Thomas Private Wealth, LLC | 16,400 | $24,108 | 0.0% | 0.1% | 0.0% |
| 20 | Virtu Financial LLCNEW | 11,574 | $17 | 0.0% | 0.1% | new |
| 21 | FIFTH THIRD BANCORP | 10,000 | $14,700 | 0.0% | 0.1% | 0.0% |
| 22 | UBS Group AG | 8,150 | $11,981 | 0.0% | 0% | -74.8% |
| 23 | Vanguard Global Advisers, LLC | 2,512 | $3,693 | 0.0% | 0% | 0.0% |
| 24 | INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 2,000 | $2,900 | 0.0% | 0% | 0.0% |
| 25 | Tower Research Capital LLC (TRC) | 810 | $1,191 | 0.0% | 0% | -74.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.